Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm Seite 1

11.10.2023 - ORLANDO, FL / ACCESSWIRE / October 11, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has completed the market assessment and commercialization ... Seite 1

Related Keywords

United States ,Gareth Sheridan ,Health Advances ,Aversa Buprenorphine ,Aversa Fentanyl ,Nutriband Chart ,Utriband Kurs ,Utriband Aktie ,